257 related articles for article (PubMed ID: 11200500)
21. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of Hoechst 33258 analogues.
Gupta R; Wang H; Huang L; Lown JW
Anticancer Drug Des; 1995 Jan; 10(1):25-41. PubMed ID: 7535056
[TBL] [Abstract][Full Text] [Related]
22. Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove.
Brooks N; McHugh PJ; Lee M; Hartley JA
Chem Biol; 2000 Sep; 7(9):659-68. PubMed ID: 10980446
[TBL] [Abstract][Full Text] [Related]
23. DNA alkylation and interstrand cross-linking by treosulfan.
Hartley JA; O'Hare CC; Baumgart J
Br J Cancer; 1999 Jan; 79(2):264-6. PubMed ID: 9888467
[TBL] [Abstract][Full Text] [Related]
24. Effect of nucleosome structure on DNA interstrand cross-linking reactions.
Millard JT; Spencer RJ; Hopkins PB
Biochemistry; 1998 Apr; 37(15):5211-9. PubMed ID: 9548752
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.
Anderson FM; O'Hare CC; Hartley JA; Robins DJ
Anticancer Drug Des; 2000 Apr; 15(2):119-26. PubMed ID: 10901299
[TBL] [Abstract][Full Text] [Related]
26. DNA-directed alkylating ligands as potential antitumor agents: sequence specificity of alkylation by intercalating aniline mustards.
Prakash AS; Denny WA; Gourdie TA; Valu KK; Woodgate PD; Wakelin LP
Biochemistry; 1990 Oct; 29(42):9799-807. PubMed ID: 2271617
[TBL] [Abstract][Full Text] [Related]
27. A New Cross-Link for an Old Cross-Linking Drug: The Nitrogen Mustard Anticancer Agent Mechlorethamine Generates Cross-Links Derived from Abasic Sites in Addition to the Expected Drug-Bridged Cross-Links.
Nejad MI; Johnson KM; Price NE; Gates KS
Biochemistry; 2016 Dec; 55(50):7033-7041. PubMed ID: 27992994
[TBL] [Abstract][Full Text] [Related]
28. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
29. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
30. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
31. Sequence-specific DNA interactions by novel alkylating anthracycline derivatives.
Marchini S; Gonzalez Paz O; Ripamonti M; Geroni C; Bargiotti A; Caruso M; Todeschi S; D'Incalci M; Broggini M
Anticancer Drug Des; 1995 Dec; 10(8):641-53. PubMed ID: 8595123
[TBL] [Abstract][Full Text] [Related]
32. Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies.
Martin C; Ellis T; McGurk CJ; Jenkins TC; Hartley JA; Waring MJ; Thurston DE
Biochemistry; 2005 Mar; 44(11):4135-47. PubMed ID: 15766241
[TBL] [Abstract][Full Text] [Related]
33. The minor groove covalent reactive drugs anthramycin and (+)-CC-1065 and their interstrand cross-linking derivatives.
Hurley LH
IARC Sci Publ; 1994; (125):295-312. PubMed ID: 7806319
[No Abstract] [Full Text] [Related]
34. Conjugation of a hairpin pyrrole-imidazole polyamide to a quinone methide for control of DNA cross-linking.
Kumar D; Veldhuyzen WF; Zhou Q; Rokita SE
Bioconjug Chem; 2004; 15(4):915-22. PubMed ID: 15264882
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, DNA interactions and biological activity of DNA minor groove targeted polybenzamide-linked nitrogen mustards.
Atwell GJ; Yaghi BM; Turner PR; Boyd M; O'Connor CJ; Ferguson LR; Baguley BC; Denny WA
Bioorg Med Chem; 1995 Jun; 3(6):679-91. PubMed ID: 7582946
[TBL] [Abstract][Full Text] [Related]
36. DNA interstrand cross-linking, DNA sequence specificity, and induced conformational changes produced by a dimeric analog of (+)-CC-1065.
Ding ZM; Hurley LH
Anticancer Drug Des; 1991 Nov; 6(5):427-52. PubMed ID: 1662513
[TBL] [Abstract][Full Text] [Related]
37. Highly efficient sequence-specific DNA interstrand cross-linking by pyrrole/imidazole CPI conjugates.
Bando T; Narita A; Saito I; Sugiyama H
J Am Chem Soc; 2003 Mar; 125(12):3471-85. PubMed ID: 12643709
[TBL] [Abstract][Full Text] [Related]
38. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.
Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA
J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786
[TBL] [Abstract][Full Text] [Related]
39. Implications of enzymatic, acidic and thermal hydrolysis of DNA on the occurrence of cross-linked melphalan DNA adducts.
Van den Driessche B; Lemière F; Witters E; Van Dongen W; Esmans EL
Rapid Commun Mass Spectrom; 2005; 19(4):449-54. PubMed ID: 15655794
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
